CONFLUENCE LIFE SCIENCES, INC.

Basic Information

4320 FOREST PARK AVE STE 303
SAINT LOUIS, MO, 63108-2979

http://confluencelifesciences.com

Company Profile

Biotechnology company focused on human drug research and development.

Additional Details

Field Value
DUNS: 961930075
Hubzone Owned: Y
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 32


  1. Development of TAK1 Compounds for Neonatal Onset Multisystem Inflammatory Disease

    Amount: $224,850.00

    DESCRIPTION (provided by applicant): Cryopyrin-associated periodic syndromes (CAPS) are a family of rare autoinflammatory diseases of which neonatal-onset multisystem inflammatory disease (NOMID) is t ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Monodispersed magnetic nanoparticles for improved diagnostic imaging. Phase II: S

    Amount: $289,278.00

    DESCRIPTION (provided by applicant): Pancreatic cancer (PC) is the fourth leading cause of death from cancer in the US. Treatment options for this disease are extremely limited and prognosis is poor. ...

    SBIR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government